Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | cathepsin CPC1 | 0.0324 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0324 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0191 | 0.336 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0324 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0324 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0324 | 1 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0324 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0257 | 0.665 | 0.5 |
Echinococcus granulosus | geminin | 0.0191 | 0.336 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0201 | 0.3886 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0324 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 100 % | Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 10 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control | ChEMBL. | 20430485 |
Inhibition (functional) | = 100 % | Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control | ChEMBL. | 20430485 |
IZ (functional) | = 14 mm | Antifungal activity against Candida albicans NCIM 3100 after 72 hrs by disc diffusion method | ChEMBL. | 20430485 |
IZ (functional) | = 18 mm | Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by disc diffusion method | ChEMBL. | 20430485 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by disc diffusion method | ChEMBL. | 20430485 |
MIC (functional) | = 50 ug ml-1 | Antifungal activity against Candida albicans NCIM 3100 after 72 hrs by disc diffusion method | ChEMBL. | 20430485 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.